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Abstract
Background: In this study, we aimed to develop and validate an instrument that could be used by patients with
cancer to evaluate their quality of palliative care.
Methods: Development of the questionnaire followed the four-phase process: item generation and reduction,
construction, pilot testing, and field testing. Based on the literature, we constructed a list of items for the quality of
palliative care from 104 quality care issues divided into 14 subscales. We constructed scales of 43 items that only
the cancer patients were asked to answer. Using relevance and feasibility criteria and pilot testing, we developed a
44-item questionnaire. To assess the sensitivity and validity of the questionnaire, we recruited 220 patients over
18 years of age from three Korean hospitals.
Results: Factor analysis of the data and fit statistics process resulted in the 4-factor, 32-item Quality Care
Questionnaire-Palliative Care (QCQ-PC), which covers appropriate communication with health care
professionals (ten items), discussing value of life and goals of care (nine items), support and counseling for
needs of holistic care (seven items), and accessibility and sustainability of care (six items). All subscales and
total scores showed a high internal consistency (Cronbach alpha range, 0.89 to 0.97). Multi-trait scaling
analysis showed good convergent (0.568–0.995) and discriminant (0.472–0.869) validity. The correlation
between the total and subscale scores of QCQ-PC and those of EORTC QLQ-C15-PAL, MQOL, SAT-SF, and DCS
was obtained.
Conclusion: This study demonstrates that the QCQ-PC can be adopted to assess the quality of care in
patients with cancer.
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Background
Despite advances in cancer therapy for cancer, most pa-
tients with cancer still suffer due to the disease itself, as
well as its treatment [1–3]. Patients with cancer have fa-
tigue, pain, loss of appetite, depression, and social and
spiritual distress [1]. Considering these various aspects,
the definition of quality of life (QOL) in cancer patients
is included personal insights of cancer patients’ symp-
toms, including physical, mental, social, and cognitive
functions [4]. As attention to QOL in oncologic care
throughout the cancer trajectory has increased, palliative
care is being better integrated into oncologic care at
earlier stages, than in the past [1–3].
The World Health Organization (WHO) defines pal-
liative care as “an approach that improves the QOL of
patients and their families facing the problems associated
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with life-threatening illness, through the prevention and re-
lief of suffering by means of early identification and impec-
cable assessment and treatment of pain and other
problems, physical, psychosocial, and spiritual”. Recently, it
was demonstrated that early palliative care resulted in not
only a significant improvement in QOL [5–7], but also lon-
ger survival among patients with cancer [5, 8].
Because palliative care is one of the factors that in-
fluences the patient’s QOL, it is also important that
the patient is provided with palliative care of good
quality defined by two crucial, humane dimensions:
high quality of care, and full acceptance of the pa-
tient’s intentions so that care is provided in a humane
and culturally appropriate manner [9].
To design palliative care intervention strategies tailored
to the patient, it is crucial to identify patients at a high risk
for poor quality care by using a valid assessment tool.
However, most instruments measure quality of care in pa-
tients at end of life (EOL) [10–15]. There are few assess-
ment tools focusing on quality of care in patients with
cancer receiving palliative care [16, 17], and there are limi-
tations in that most of the current palliative care assess-
ment tools did not include spiritual and cultural domains,
and there are few tools to assess the EOL care experience
reported by the patient [18]. In addition, most of the pal-
liative care assessment tools developed so far measure the
QOL of the patient, not the quality of care [19–23].
Therefore, in the present study, we aimed to develop a
new instrument to assess quality of palliative care and
report on the validation of the developed tool, which is




QCQ-PC includes four stages of development proposed
by the European Organization for Research and Treat-
ment of Cancer Quality of-Life Group [24]: 1) item gen-
eration and reduction; 2) scale construction; 3) pilot
testing; and 4) field testing. The study was approved by
the Institutional Review Board of the Seoul National
University Hospital, Korea. Suitable patients signed in-
formed consent forms. The requirements for the recruit-
ment of patients were as follows: (1) 18 years old or
older; (2) diagnosed with cancer (cancer was confirmed
by oncologists); (3) able to read and comprehend Ko-
rean, be able to fill in the questionnaire; and (4) aware of
cancer diagnosis.
Phase I: Item generation and reduction
Phase I was intended to gather a list of relevant quality
of palliative care questionnaires and previous palliative
care clinical guidelines. We performed an extensive lit-
erature review using PUBMED and other databases
searching the keywords ‘palliative care’, ‘end of life care’,
and ‘quality of care’. We conclusively reviewed and
adopted End of Life Quality Standards (2013) published
by The National Institute for Health and Care Excellence
(NICE) in the United Kingdom, Clinical Practice Guide-
lines for Quality Palliative Care (3rd Ed. 2013) released
by National Consensus Project (NCP) in the United
States and A National Framework and Preferred Prac-
tices for Palliative and Hospice Care Quality issued by
National Quality Forum (NQF) in the United States.
We also considered the quality of care index of the
prior study. We investigated and used the Assessment of
Chronic Illness Care (ACIC) questionnaire and the Pa-
tient Assessment of Chronic Illness Care (PACIC) ques-
tionnaire translated by National Evidence-based
Healthcare Collaborating Agency (NECA) in a previous
study, which was a study of the performance evaluation
methods of sub-categories in the management of chronic
disease patients in a community by the primary health
care center (2015). In addition, the FAMCARE Patient
Scale developed by Kristjanson (1993) and verified with
respect to validity and reliability was used. Based on the
literature, we constructed a list of items for the QCQ-
PC from 104 quality care issues divided into 14 scales.
We discussed these 104 items in semi-structured inter-
views with 31 health care professionals in November
2016 and December 2016. The health care professionals
participating in the survey included physicians, nurses,
and social workers who worked in university hospitals
and were engaged in palliative care. The semi-structured
interviews did not include patients because the items
built by healthcare professionals were intended to be
pilot-tested separately. The survey was conducted twice
in total, and the respondents evaluated the validity and
feasibility of the developed items by scoring them on a
scale from 1 to 5. In the second investigation, the aver-
age score of all respondents for each item was compared
with the score given by them, and the score changed
when the respondent’s evaluation changed. The items
that did not meet the following criteria in both the pri-
mary and secondary surveys were deleted (in the case of
validity, if the respondent average score was three or
more, or the respondent score was less than three points
in less than 25% of the respondents; in the case of feasi-
bility, the respondent average score is 2.5 or more, or
less than three points in less than 30% of the total re-
spondents). Thirteen items (12.5% of the developed
items) that did not meet the criteria were deleted; there-
fore, a total of 91 items were included in the final index.
Phase II: Scale construction
Among the 91 palliative care quality evaluation indices
developed through the process of item development and
reduction, we constructed scales of 43 items that only
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the patients were asked to answer. The 48 items that
were excluded were the items that directly asked the
medical staff to evaluate the quality of care. For the scor-
ing format, we selected a four-point Likert scale for all
of 43 items to evaluate in phase III (Strongly Agree,
Agree, Disagree, Strongly Disagree – see Additional file 1:
Appendix B).
Phase III: Pilot testing
We conducted pilot tests to find possible administration
problems, such as miss-phrasing, and to determine
which items should be modified or removed. Before field
testing, a total of 15 cancer patients responded to the
QCQ-PC questionnaire and debriefed the questionnaire.
The mean age of the 15 patients was 60.6 years, with 7
males and 8 females. Regarding educational level, most
subjects had more than college or university education.
All 15 patients were collected from Seoul National Uni-
versity Hospital. All 15 patients were collected from
Seoul National University Hospital. The questionnaire
designed for debriefing included which questions were
misleading, whether the respondents were offended, or
whether they were unable to respond. After the ques-
tionnaire, we received comments on the questionnaire.
Taking into consideration the responses of these debrief-
ing questionnaires, we clarified and simplified the items
that were difficult to understand or answer. We also
added one item to reflect the needs of the respondents.
Phase IV: Field testing
To confirm reliability and validity, we performed a field
test with the QCQ-PC questionnaire.
Because the most patients group receiving palliative
care are patients diagnosed with cancer, we performed
this field testing for the QCQ-PC questionnaire to
cancer patients. To obtain a heterogeneous sample by
cancer type, patients were recruited to include various
primary sites of cancer; these patients were registered
at four university hospitals in Korea. We included pa-
tients under curative treatment as well as patients
under palliative treatment. This study used factor ana-
lysis with varimax rotation to analyze construct valid-
ity, and performed multi-trait scaling analysis to
examine the extent to which QCQ-PC items could be
combined into a more controlled multi-item set. For
validation, we applied ten rules, for which at least five
respondents were required per item [25, 26]. Since we
had a total of 44 questions, 220 respondents were ne-
cessary for the validation process.
We investigated the correlation between each question
and the scale that included that question, and estimated
the convergent validity of the QCQ-PC items. In verify-
ing discriminant validity, we assessed the magnitude of
the correlation of an item with its own scale as
compared to other scales. We considered the convergent
validity of items by analyzing correlations that were ≥0.4,
and corrected for overlap, as confirmation of validity
[27]. We identified scaling errors as cases in which an
item correlated significantly less with its own scale as
compared to its correlation with other scales. To test the
reliability of QCQ-PC, we estimated Cronbach alpha, a
degree of internal consistency of responses. An alpha
≥0.70 was generally regarded as acceptably high for the
collection of responses into a single score [28].
Furthermore, fit statistics (INFIT/OUTFIT) analysis
was performed to evaluate the fitness of the item re-
sponse, and it was interpreted as a good response
when the fit was between 0.7 and 1.3 [29]. The slope
was checked to confirm the discrimination of the
items. In the case of a fit value less than 1.5, the dis-
crimination of the items was considered unsuitable
(see Additional file 1: Appendix A).
Additional evaluation
We asked the respondents to fill in additional ques-
tionnaires on previous validated scales. The following
questionnaires were included: The European
Organization for Research and Treatment of Cancer
Quality of Life Questionnaire Core-15 item palliative
care (EORTC QLQ–C15-PAL) measuring patient-
reported QoL [30], the McGill Quality of Life Ques-
tionnaire (MQOL) constructed by physical symptoms,
psychological symptoms, existential well-being, and
support [31], the Smart Management Strategy for
Health Assessment Tool – Short Form (SAT-SF) for
self-management strategies assessments [32], and the
Decisional Conflict Scale (DCS) - assesses the level of
‘decisional conflict’ that patients experience while
making health care decisions [33].
Data analyses were conducted using WINSTEP ver-
sion 4.0 for item-fit analysis, and SPSS version 24.0 for
other statistical analyses.
Results
A total of 220 patients under curative or palliative
therapy were enrolled in this study during the 2-
month survey period. Most patients (96.4%) com-
pleted the questionnaire, but eight patients were ex-
cluded from the analysis because they did not answer
more than three items. The remaining 212 patients
included in the analysis responded to all questions.
The demographic characteristics of patients who
participated in the study are shown in Table 1. There
was no significant difference in gender ratio; more
than half the patients were aged between 50 and
69 years old, and most patients were being treated.
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Factor analysis
We conducted factor analysis on the total sample of re-
spondents (n = 220). We initially had four significant fac-
tors with 44 items; twelve items were discarded through
the fit statistics process. Upon reanalysis of the
remaining 32 items, the items were classified according
to four significant factors. Table 2 lists the item-to-factor
correlations for the 32 items and four factors – factor 1:
appropriate communication with health care profes-
sionals (ten items); factor 2: discussing value of life and
goals of care (nine items); factor 3: support and counsel-
ing for needs of holistic care (seven items); and factor 4:
accessibility and sustainability of care (six items). We
attained similar of factor analysis results with both mul-
tiple and simple imputations.
Reliability
Table 3 shows the mean and reliability of the QCQ-PC
subscale. In all four scales, the degree of reliability was
high, with good internal consistency (Cronbach alpha
range: 0.889–0.973).
Validity: Multi-trait scaling analysis
When item-to-self scale correlations were tested, all
item-convergent validity exceeded 0.4. Other scales were
also compared through item-discriminant validity, and
no scaling error was observed.
Additional evaluation
Additional evaluationMQOL
We obtained the correlation between total and subscale
scores of QCQ-PC and EORTC QLQ-C15-PAL and
MQOL (see Table 4). Both total and subscale scores sig-
nificantly correlated with the emotional functioning and
global health scores of EORTC QLQ-C15-PAL (Pearson
correlation [r] range 0.165–0.278). Existential well-being
and support scores of MQOL significantly correlated
with both the total and subscale scores of QCQ-PC
(Pearson correlation [r] range 0.218–0.341, p < 0.001).
However, total and subscale scores of QCQ-PC did not
correlate with physical functioning.
Comparisons with SAT-SF (smart management strategy for
health assessment tool – Short form) scores
SAT is a tool to identify self-management strategies of
cancer patients. We used the short form of SAT to exam-
ine the association with the QCQ-PC score. As expected,
there was a significant correlation between the SAT total
score and the QCQ-PC score (Pearson correlation [r]
range 0.285–0.372, p < 0.001). Compared to each subscale
of SAT, significant correlation was observed (Pearson cor-
relation [r] range 0.239–0.375, p < 0.001).
Comparisons with DCS
QCQ-PC scores showed correlation with the DCS total
score and subscale score (Pearson correlation [r] range
0.325–0.397, 0.200–0.384). DCS is scored in the opposite
direction; the higher the score, the higher the decision
conflict.
Discussion
The 32-item QCQ-PC is patient-reported and has excel-
lent psychometric properties. The QCQ-PC consists of
four factors that focus on communication with health
care professionals, discussing value of life and goals of
care, support and counseling for holistic care needs, and
accessibility and continuity of care, all of which are cen-
tral issues in palliative care. Our results are consistent
with the findings of many previous studies and recom-
mendations [1, 3, 6], but diverge in terms of quality of
care at EOL [10–15]. The factors are unique and differ-
ent from standard oncology care [6].
Table 1 Demographic and clinical characteristics of the
Participants (N=212)
Characteristics N (%)






Sex Male 100 (47.2)
Female 112 (52.8)
Education ≤Elementary school 29 (13.8)
Middle school 20 (9.5)
High school 72 (34.1)
≥College or University 90 (42.7)





Urinary system 17 (8.0)
Pancreato-biliary system 16 (7.5)
Others 17 (8.0)
Therapeutic statusb At diagnosis 4 (1.9)
In treatment 162 (76.8)
< 5 yrs. since treatment 31 (14.7)
≥5 yrs. since treatment 14 (6.6)
aPrimary site of cancer
bTherapeutic status of cancer
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This study suggests that QCQ-PC has excellent psy-
chometric properties, such as high construct validity and
internal consistency. That QCQ-PC exhibited less cor-
relation with EORTC QLQ-C15-PAL than with MQOL,
and does not have significant correlation with physical
functioning, suggesting that QCQ-PC more measures
the emotional, social, and spiritual aspects of care in pal-
liative settings rather than symptom control. Addition-
ally, most correlations of QCQ-PC subscales with QOL
subscales were below 0.4, suggesting that QCQ-PC may
differentiate aspects of palliative care from those ad-
dressed by the QOL assessment tools. Therefore, QCQ-
Table 2 Factor analysis of 32 QCQ-PC Items
QCQ-PC items Factorb
Noa Questions Factor 1 Factor 2 Factor 3 Factor 4
3 I am satisfied with the careful manner of medical staff 0.767 0.164 0.334 0.148
6 I am satisfied with the way of communication of medical staff 0.755 0.212 0.350 0.118
2 I was able to receive adequate care from medical staff 0.742 0.163 0.219 0.149
7 I have heard and understood an accurate description of the progress of my disease 0.734 0.304 0.105 0.186
11 The medical staff explained terms that I was curious about 0.662 0.245 0.326 0.219
4 I was able to receive the healthcare service I demanded 0.634 0.378 0.106 0.370
9 The medical staff support my decision on care plan 0.601 0.446 0.091 0.495
8 I have heard and understood an accurate description of my care plan 0.600 0.441 0.026 0.433
43 I was able to have a conversation with medical staff in a relaxed atmosphere 0.583 0.222 0.581 0.119
25 The medical staff paid attention to various symptoms I felt and adjusted them well 0.580 0.097 0.446 0.300
13 I was able to discourse with medical staff about the value of my life 0.305 0.737 0.375 0.044
14 I was able to recall what is important to achieve the values and goals of my life while
discoursing with medical staff
0.250 0.709 0.432 0.032
16 I was able to express what my family and I expected from care 0.310 0.704 0.229 0.289
18 My care plans included the things I was able to try myself 0.141 0.684 0.115 0.336
19 I was able to receive adequate help from medical staff, while I was having difficulties in
setting up specific goals related to care
0.196 0.683 0.324 0.358
17 My family and I received an education that is helpful to care 0.246 0.670 0.333 0.226
21 The medical staff suggested an adequate care plan in consideration of values of my life 0.303 0.599 0.289 0.434
22 I was able to modify my plan when my demand for treatment changed 0.279 0.557 0.274 0.395
12 The medical staff managed intermediate checkups to verify whether I could execute my goals 0.509 0.544 0.180 0.284
44 I was able to receive outpatient care and telephone counseling with plenty of time 0.325 0.293 0.702 0.123
30 The medical staff provide support to me and my family to solve spiritual concerns 0.043 0.360 0.647 0.225
29 The medical staff provided support to me and my family to overcome social crisis 0.224 0.451 0.620 0.262
33 The medical staff knew what I wanted 0.257 0.187 0.619 0.382
28 The medical staff communicated smoothly with me and my family 0.291 0.255 0.592 0.380
41 Outpatient care and telephone counseling were done at the appointed time without delay 0.483 0.138 0.524 0.078
27 My family and I received psychological support from medical staff 0.242 0.299 0.508 0.424
35 Services needed for my care are provided by experts in their respective fields 0.148 0.228 0.367 0.706
36 I was able to get care services at the locations I wanted 0.237 0.293 0.404 0.669
38 Medical care is immediately provided in a state of crisis 0.315 0.228 0.340 0.552
23 The medical staff periodically confirmed my goals and plans toward care 0.275 0.482 0.341 0.540
10 The decision on a healthcare plan was reflected by my family and my opinions 0.485 0.419 0.009 0.517
5 I understand the goal of care 0.429 0.450 0.151 0.503
Results from orthogonal (varimax) rotation analysis. Bold type indicates loading > 0.5
aThe number of each item is its number in the QCQ-PC questionnaires
bFactor 1: Appropriate communication with health care professionals; Factor 2: Discussing value of life and goals of care; Factor 3: Support and counseling for
needs of holistic care; Factor 4: Accessibility and sustainability of care
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PC is recommended for use together with a QOL assess-
ment tool, such as EORTC QLQ-C15-PAL, in order to
more accurately to measure the quality of care.
In this study, QCQ-PC had significant negative correl-
ation between the total and subscale scores and the DCS
scores. Lack of communication with healthcare profes-
sionals and discussing value of life and goals of care may
cause patient dissatisfaction with respect to care during
cancer treatment, and lead patients to choose interven-
tions that physicians believe are inappropriate. In
addition, it is particularly crucial for healthcare providers
to support and counsel on holistic care needs, to deliver
continuous palliative care for patients with cancer, to
maintain good interpersonal relationships with them,
and to relieve their decisional conflict [1, 2, 6, 10]. We
can improve their decision conflicts by recognizing high
risk groups in quality care and providing palliative care.
Perhaps the most interesting finding of this study is
that QCQ-PC appears to be sensitive to health manage-
ment in palliative care settings. Using a conceptual
model, self-health management with cancer can be influ-
enced by quality care including communication with
health care professionals, discussing value of life and
goals of care, support and counseling for holistic care
needs, and accessibility and continuity of care. Our find-
ings showing that the QCQ-PC scales were associated
with strategy scales for health management support this
conceptual model.















Total 32 0–100 2.813
(0.555)
0.973




0.940 0.699–0.858 0.527–0.760 40/40 0




0.935 0.691–0.852 0.514–0.740 36/36 0




0.889 0.568–0.839 0.472–0.721 28/28 0




0.896 0.655–0.885 0.512–0.869 24/24 0
Abbreviations: QCQ-PC Quality Care Questionnaire – Palliative Care, SD Standard deviation
Table 4 Pearson correlations of QCQ-PC with other validated questionnaires (EORTC QLQ-C15-PAL, MQOL, SAT-SF, DCS)
QCQ-PC subscale
Total score Factor 1 Factor 2 Factor 3 Factor 4
EORTC-PAL Physical functioning 0.076 0.091 0.034 0.089 0.089
Emotional functioning 0.229*** 0.259*** 0.165* 0.231*** 0.236***
Global health 0.240*** 0.278*** 0.185** 0.206** 0.242***
McGill QOL Existential well-being 0.323*** 0.341*** 0.237*** 0.292*** 0.308***
Support 0.305*** 0.310*** 0.218*** 0.285*** 0.299***
SAT-SF strategies Total 0.363*** 0.351*** 0.285*** 0.305*** 0.372***
Core strategies 0.304*** 0.310*** 0.239*** 0.242*** 0.321***
Preparation strategies 0.375*** 0.354*** 0.301*** 0.316*** 0.373***
Implementation strategies 0.344*** 0.324*** 0.261*** 0.301*** 0.354***
DCS Total −0.397*** −0.357*** −0.378*** −0.325*** −0.376***
Uncertainty −0.367*** −0.324*** − 0.347*** − 0.323*** − 0.348***
Informed − 0.282*** − 0.265*** − 0.251*** − 0.204** − 0.275***
Values clarity − 0.267*** −0.200** − 0.268*** −0.235*** − 0.241***
Support −0.384*** −0.366*** − 0.374*** −0.317*** − 0.353***
Effective decision −0.349*** −0.327*** − 0.329*** −0.270*** − 0.344***
Abbreviation: EORTC QLQ-C15-PAL European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core-15 item palliative care, McGill
QOL McGill Quality of Life Questionnaire, SAT Smart Management Strategy for Health (SMASH) Assessment Tool, DCS Decisional Conflict Scale
*** P < 0.001, ** p < 0.01, * p < 0.05
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Study limitations
This study has several limitations. First, since our re-
search was conducted only in Korea, cross-cultural val-
idation studies are necessary for generalizations to other
countries. Second, we did not assess test-retest. As QOL
and quality of care among cancer patients can frequently
change, test-retest may not be feasible and may not limit
the psychometric properties of this QCQ-PC. Finally, as
this study relied exclusively on patients with cancer, our
findings might not be generalizable to non-cancer pa-
tients who need palliative care. Furthermore, our study
included not only incurable cancer patients, but also pa-
tients who had received treatment more than 5 years
previously. However, to assess the quality of early pallia-
tive care as well, it may be preferable to include all can-
cer patients rather than only those with incurable cancer
for constructing the questionnaire. We suggested that it
is necessary to investigate further research on the pa-
tients of early palliative care and palliative care with this
QCQ-PC questionnaire. Though, some modification of
items among the QCQ-PC might be applied to patients
with other advanced diseases.
Conclusion
In conclusion, we believe that this QCQ-PC, a self-
reported assessment tool with proper psychometric
properties, can be effectively used to identify patients
with cancer at high risk, and to evaluate the efficacy of
trials, such as palliative care with the QOL assessment
tool.
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